Caris
Caris Life Sciences, ConcertAI to Collaborate on Database Project
The firms plan to create a research platform that brings together molecular and clinical data for drug development and clinical trials management.
Caris Life Sciences, Flare Therapeutics Collaborate to Advance Oncology Programs
Flare will leverage Caris' capabilities in sequencing, data analytics, and biomarker-driven patient selection to advance five of its pipeline programs.
Caris to Provide Biomarker Discovery, Molecular Testing for Incyte Oncology Drug Development
Pharma firm Incyte is working with Caris on two drug programs initially, with the option to expand to four in total and the possibility of CDx partnerships.
Caris Life Sciences Raises $400M in Senior Secured Debt Financing
The company said it will use the proceeds to repay outstanding debt and enhance its precision medicine platform, in addition to funding general corporate activities.
Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform
Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology.